Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueNo recent work listed

Jérémy Nigri

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1358-1863; OpenAlex author ID A5028284048. Sources: OpenAlex.

Their work

Papers
14 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
62
Papers, trials and grants by year

2015: 2 papers · 2016: 2 papers · 2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 3 papers · 2023: 1 paper

Papers 14

  1. SK2 channels set a signalling hub bolstering CAF-triggered tumourigenic processes in pancreatic cancer. First author DOI 10.1136/gutjnl-2021-326610↗
  2. Sympathetic axonal sprouting induces changes in macrophage populations and protects against pancreatic cancer. Co-author DOI 10.1038/s41467-022-29659-w↗
  3. CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cell aggressiveness. Co-author DOI 10.1126/scisignal.abg8191↗
  4. Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. Co-author DOI 10.15252/embj.2021110466↗
  5. Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages. Co-author DOI 10.1016/j.jcmgh.2021.01.008↗
  6. The Cellular and Biological Impact of Extracellular Vesicles in Pancreatic Cancer. First author DOI 10.3390/cancers13123040↗
  7. Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer. First author DOI 10.1136/gutjnl-2018-317570↗
  8. Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma. Co-author DOI 10.1080/2162402x.2018.1504727↗
  9. LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker. Co-author DOI 10.1158/0008-5472.can-15-2790↗
  10. PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker. Co-author DOI 10.1007/s00018-017-2579-9↗
  11. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma. First author DOI 10.1038/cdd.2016.18↗
  12. Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness. Co-author DOI 10.1172/jci87734↗
  13. Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling. Co-author DOI 10.1038/cddis.2014.557↗
  14. Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma. Co-author DOI 10.1073/pnas.1421601112↗

Closest collaborators

The 25 strongest of 62 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Richard Tomasini · 14 shared papers, 2015–2023 · strength 1.26
  2. Fabienne Guillaumond · 7 shared papers, 2015–2022 · strength 0.56
  3. Juan Iovanna · 8 shared papers, 2015–2022 · strength 0.54
  4. Sophie Vasseur · 7 shared papers, 2015–2022 · strength 0.49
  5. Nelson Dusetti · 5 shared papers, 2015–2023 · strength 0.45
  6. Julie Leca · 6 shared papers, 2015–2022 · strength 0.45
  7. François Bertucci · 3 shared papers, 2022–2023 · strength 0.40
  8. Corinne Bousquet · 5 shared papers, 2015–2023 · strength 0.39
  9. Zainab Hussain · 2 shared papers, 2021–2023 · strength 0.37
  10. Christian Bressy · 5 shared papers, 2015–2018 · strength 0.25
  11. Julie Roques · 4 shared papers, 2015–2018 · strength 0.20
  12. Mehdi Ouaïssi · 4 shared papers, 2015–2018 · strength 0.18
  13. Sébastien Martinez · 2 shared papers, 2016–2022 · strength 0.18
  14. Rémi Samain · 2 shared papers, 2019–2021 · strength 0.17
  15. Daniel Pietrasz · 3 shared papers, 2016–2018 · strength 0.17
  16. Jean‐Baptiste Bachet · 3 shared papers, 2016–2018 · strength 0.17
  17. Victoire Gouirand · 2 shared papers, 2015–2022 · strength 0.15
  18. Jerome F. Cros · 2 shared papers, 2017–2021 · strength 0.15
  19. Véronique Secq · 3 shared papers, 2015–2018 · strength 0.15
  20. Raphaël Rapetti‐Mauss · 1 shared paper, 2023 · strength 0.14
  21. Georgios Efthymiou · 1 shared paper, 2023 · strength 0.14
  22. Olivier Soriani · 1 shared paper, 2023 · strength 0.14
  23. Evan Chen Lien · 1 shared paper, 2022 · strength 0.11
  24. Tristan Gicquel · 1 shared paper, 2022 · strength 0.11
  25. Jérémy Guillot · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.